Istari Oncology's Unattributed - II Round

Istari Oncology raised a round of funding on May 26, 2017.

Istari Oncology was formed to advance PVS-RIPO, a genetically modified poliovirus.…

Articles about Istari Oncology's Unattributed - II Round: